Revvity RVTY Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Segment revenue by Business | ||||||
| Diagnostics | $349.27M-10.5% | $390.07M+9.5% | $356.13M+0.5% | $354.39M+9.3% | $324.37M-8.5% | |
| Life Sciences | $361.85M-5.3% | $381.99M+11.4% | $342.82M-6.3% | $365.9M+7.5% | $340.4M-9.2% | |
| Segment revenue by Geography | ||||||
| Americas | $315.99M-1.4% | $320.48M+4.3% | $307.28M-5.0% | $323.58M+6.2% | $304.63M-4.4% | |
| Asia | $172.08M-19.7% | $214.42M+13.3% | $189.28M-2.0% | $193.07M+8.3% | $178.34M-16.4% | |
| Europe | $223.05M-6.0% | $237.16M+17.2% | $202.4M-0.6% | $203.63M+12.0% | $181.79M-7.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Revvity break its business down?
- Revvity (RVTY) reports segment revenue by business across 2 parts — Diagnostics and Life Sciences. Each is extracted from the segment footnotes and tracked over time.
- Where does Revvity's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Revvity's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
